Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Vocke Website

Cathy D. Vocke, Ph.D.

Selected Publications

1)  Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM.
Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Cancer Res. 56: 2411-6, 1996.
[Journal]
2)  Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM.
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.
J. Natl. Cancer Inst. 97: 931-5, 2005.
[Journal]
3)  Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R, Tsokos M, Merino MJ, Pavlovich CP, Ried T, Linehan WM, Vocke CD.
The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dube gene pathway.
Cancer Genet. Cytogenet. 180: 100-9, 2008.
[Journal]
4)  Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM.
Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.
Genes Chromosomes Cancer. 50: 466-77, 2011.
[Journal]
5)  Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM.
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.
J. Urol. 188: 2063-71, 2012.
[Journal]
6)  Shuch B, Agochukwu N, Ricketts CJ, Vocke CD, Gautam R, Merino MJ, Linehan WM, Srinivasan R.
Vascular endothelial growth factor receptor-targeted therapy in succinate dehydrogenase C kidney cancer.
J Clin Oncol. 2013.
In Press. [Journal]
7)  Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM.
Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer.
J. Urol. 189: 430-5, 2013.
[Journal]
8)  Creighton C, Morgan M, Gunaratne P, Wheeler D, Gibbs R, Robertson A, Chu A, Beroukhim R, et al. .
Comprehensive molecular characterization of clear cell renal cell carcinoma.
Nature. 499: 43-9, 2013.
[Journal]
9)  Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie X, Dahia PL, Eng C, Linehan WM, Brugarolas J.
Germline BAP1 mutation predisposes to familial clear-cell renal cell carcinoma.
Mol. Cancer Res. 11: 1061-71, 2013.
[Journal]
10)  Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM.
Germline PTEN Mutation Cowden Syndrome: An Under-Appreciated Form of Hereditary Kidney Cancer.
J. Urol. 190: 1990-8, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 7/14/2014.